Industrial development in a high tech sector of a developing country: new directions and the unfinished technological transition in the Brazilian vaccine industry

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Business, Engineering, Economics

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• National Systems of Innovation : Towards a Theory of Innovation and Interactive Learning

  2012cited by this paper
• Core Capabilities and Core Rigidities: A Paradox in Managing New Product Development

  2011influential reference
• Vacina antivariólica: ciência, técnica e o poder dos homens, 1808-1920

  2011cited by this paper
• A 'History-Friendly' Model of the Evolution of the Pharmaceutical Industry

  2010cited by this paper
• Global forum for health research, forum 2009: innovating for the health of all.

  2010cited by this paper
• Building theories from case study research

  2009cited by this paper
• Bengt-Åke Lundvall - Innovation as an interactive process: from user-producer interaction to the national system of innovation

  2009cited by this paper
• A Formação de Competências para Inovar através de Processos de Transferência de Tecnologia: um estudo de caso

  2009cited by this paper
• Engaged Scholarship: A Guide for Organizational and Social Research, by Andrew H. Van de Ven. Oxford: Oxford University Press, 2007

  2008influential reference
• Contribuição dos sistemas da qualidade: proposta de modelo de gestão da qualidade para Bio-Manguinhos / Fiocruz

  2008cited by this paper
• The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.

  2008cited by this paper
• Innovation Dynamics in Catch‐Up Firms: Process, Product and Proprietary Capabilities for Development

  2008influential reference
• Organizational Capabilities, Patterns of Knowledge Accumulation and Governance Structures in Business Firms: An Introduction

  2008cited by this paper
• Brazilian health biotech—fostering crosstalk between public and private sectors

  2008cited by this paper
• The GAVI Financing Task Force: one model of partner collaboration.

  2008cited by this paper
• Inovação em saúde: dilemas e desafios de uma instituição pública

  2008cited by this paper
• UNCTAD The Least Developed Countries Report 2007 Background Paper Technological Learning and the Development of Production and Innovative Capacities in the Industry and Infrastructure Sectors of the Least Developed Countries: What Roles for ODA?

  2007influential reference
• What recent research does and doesn't tell us about rates of latecomer firms’ capability accumulation

  2007influential reference
• Access to vaccine technologies in developing countries: Brazil and India.

  2007influential reference
• Assessing the technological capabilities of firms: developing a policy tool

  2007influential reference
• The introduction of new vaccines into developing countries. IV: Global Access Strategies.

  2007cited by this paper
• The transition from building‐up innovative technological capabilities to leadership by latecomer firms

  2007influential reference
• R&D models: lessons from vaccine history

  2007influential reference
• Public biotechnology 2005—the numbers

  2006cited by this paper
• The Oxford handbook of innovation

  2006cited by this paper
• Managing the effect of TRIPS on availability of priority vaccines.

  2006cited by this paper
• Vaccine independence, local competences and globalisation: lessons from the history of pertussis vaccines.

  2006cited by this paper
• Knowledge Accumulation and Industry Evolution: Contents

  2006influential reference
• Catch-up strategies and the latecomer effect in industrial development

  2006cited by this paper
• Private biotech 2004—the numbers

  2006cited by this paper
• State of biotech sector—2005

  2006influential reference
• Sectoral Systems: How and Why Innovation Differs across Sectors

  2006cited by this paper
• Vaccine shortages: history, impact, and prospects for the future.

  2006cited by this paper
• Chapter 26: Innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries.

  2006cited by this paper
• Time and technological learning in industrialising countries: how long does it take? How fast is it moving (if at all)?

  2006cited by this paper
• Knowledge Accumulation and Industry Evolution: The evolution of pharmaceutical innovation

  2006influential reference
• Human vaccine research and development: an overview.

  2005cited by this paper
• Factors affecting U.S. manufacturers' decisions to produce vaccines.

  2005cited by this paper
• Avaliação Tecnológica da Produção de Imunobiológicos no Brasil e Definição de Nichos de Atuação

  2005cited by this paper
• Lock in, the state and vaccine development: Lessons from the history of the polio vaccines

  2005influential reference
• The business of making vaccines

  2005influential reference
• Six Revolutions in Vaccinology

  2005cited by this paper
• Desenvolvimento de Vacinas no Brasil: uma análise da potencialidade da P&D e das estratégias de inovação

  2005cited by this paper
• Imunobiológicos e Vigilância Sanitária

  2005cited by this paper
• The history of vaccines and immunization: familiar patterns, new challenges.

  2005cited by this paper
• Why are pharmaceutical companies gradually abandoning vaccines?

  2005influential reference
• Measuring technological capabilities at the country level: A survey and a menu for choice

  2005influential reference
• Desenvolvimento Tecnológico de Vacinas: projeções para 2015

  2005influential reference
• Programa Nacional de Competitividade em Vacinas (Inovacina)

  2005cited by this paper
• Vaccines: past, present and future

  2005cited by this paper
• The problems and promise of vaccine markets in developing countries.

  2005cited by this paper
• THE CHANGING LANDSCAPE OF VACCINE DEVELOPMENT – PUBLIC PRIVATE PARTNERSHIPS BETWEEN BROKERAGE AND KNOWLEDGE INTEGRATION

  2005cited by this paper
• Vacinas, soros e imunizações no Brasil

  2005cited by this paper
• O Complexo Industrial da Saúde: desafios para uma política de inovação e desenvolvimento

  2005cited by this paper
• Avaliação Gerencial dos Produtores de Vacinas no Brasil

  2005cited by this paper
• Why certain vaccines have been delayed or not developed at all.

  2005cited by this paper
• Programa nacional de imunizações (PNI): história, avaliação e perspectivas

  2005influential reference
• What is R&D? Why does it matter?

  2004cited by this paper
• The scientific muscle of Brazil's health biotechnology

  2004cited by this paper
• The myth of the biotech revolution.

  2004cited by this paper
• Research and development of new vaccines against infectious diseases.

  2004cited by this paper
• The Global Alliance for Vaccines and Immunization: is it a new model for effective public-private cooperation in international public health?

  2004influential reference
• Vaccines: preventing disease and protecting health.

  2004cited by this paper
• Book Review

  2004cited by this paper
• Systems of innovation perspectives and challenges

  2004influential reference
• Building Technological Capabilities in Latecomer Firms: A Review Essay

  2004cited by this paper
• Desenvolvimento tecnológico de vacinas em Bio-Manguinhos/Fiocruz: uma proposta de gestão

  2004cited by this paper
• Approaching the innovation frontier in Korea: the transition phase to leadership

  2004influential reference
• [Technological development: a weak link in vaccine innovation in Brazil].

  2003cited by this paper
• A brief history of the prevention of infectious diseases by immunisations.

  2003influential reference
• O complexo industrial da saúde e a necessidade de um enfoque dinâmico na economia da saúde

  2003influential reference
• Vaccinology: past achievements, present roadblocks and future promises.

  2003influential reference
• Technological capabilities in the context of export-led growth: a conceptual framework

  2003influential reference
• Technological Capabilities and Export Success in Asia

  2003influential reference
• Inovao em vacinas no Brasil: experincia recente e constrangimentos estruturais

  2003influential reference
• Innovation in Asian Industrialization: A Gerschenkronian Perspective

  2003influential reference
• Managing innovation: integrating technological, market and organisational change. (Book Reviews)

  2002influential reference
• O complexo industrial da saúde: público e privado na produção e consumo de vacinas no Brasil

  2002influential reference
• Continental, national and sub-national innovation systems--complementarity and economic growth

  2002cited by this paper
• From Followers to Leaders: Managing Technology and Innovation

  2002influential reference
• As especificidades do sistema de inovação do setor saúde

  2002cited by this paper
• Innovation and market structure in the dynamics of the pharmaceutical industry and biotechnology: towards a history‐friendly model

  2002cited by this paper
• The Qualitative Researcher's Companion

  2002cited by this paper
• Technological Learning and Competitive Performance

  2001influential reference
• WHO expectation and industry goals.

  2001cited by this paper
• Managing Innovation: Integrating Technological, Market, and Organizational Change, 2nd Edition

  2001cited by this paper
• Key drivers behind the development of global vaccine market.

  2001influential reference
• The future of vaccines: an industrial perspective.

  2001influential reference
• Business perspectives of a European vaccine manufacturer.

  2001cited by this paper
• Febre amarela: a doença e a vacina, uma história inacabada

  2001influential reference
• Complementary Assets, Strategic Alliances, and the Incumbent's Advantage: An Empirical Study of Industry and Firm Effects in the Biopharmaceutical Industry

  2001cited by this paper
• Technological regimes, catching-up and leapfrogging: findings from the Korean industries

  2001cited by this paper
• Vaccines in historic evolution and perspective: a narrative of vaccine discoveries.

  2000cited by this paper
• The Political Economy of Science Technology and Innovation.

  2000cited by this paper
• Analise de processos de reorganização de institutos publicos de pesquisa do estado de São Paulo

  2000cited by this paper
• Learning and Knowledge Management in the Firm

  2000influential reference
• International technology transfer and catch-up in economic development

  1999cited by this paper
• Vacina antivariólica: ciência, técnica e o poder dos homens 1808-1920

  1999cited by this paper
• New technologies for making vaccines.

  1999cited by this paper
• Technology, Management and Systems of Innovation

  1999influential reference

• The evolution and use of a policy and research tool: assessing the technological capabilities of firms

  2014influential citation